XML 127 R106.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended
Dec. 27, 2013
Sep. 26, 2014
Sep. 27, 2013
Sep. 28, 2012
Jul. 31, 2014
Transpire, Inc.
Jul. 31, 2014
Transpire, Inc.
Oncology Systems Reporting Unit
Jul. 31, 2014
Transpire, Inc.
Security and Inspection Products Reporting Unit
Apr. 30, 2014
Velocity Medical Solutions LLC
Apr. 30, 2012
InfiMed, Inc.
Jul. 31, 2014
Developed Technology
Transpire, Inc.
Apr. 30, 2014
Developed Technology
Velocity Medical Solutions LLC
Jul. 31, 2014
Customer Relationships
Transpire, Inc.
Apr. 30, 2014
Customer Relationships
Velocity Medical Solutions LLC
Jul. 31, 2014
Trade Name
Transpire, Inc.
Apr. 30, 2014
Trade Name
Velocity Medical Solutions LLC
Jul. 31, 2014
In-process Research and Development
Transpire, Inc.
Oncology Systems Reporting Unit
Business Acquisition [Line Items]                                
Total purchase price $ 1,500,000       $ 19,300,000     $ 19,900,000 $ 20,800,000              
Cash consideration         16,000,000     17,000,000 17,100,000              
Contingent consideration liabilties   7,500,000 2,500,000   3,300,000     2,900,000 3,700,000              
Allocated to amortizable intangible assets         10,700,000 8,000,000 2,700,000 10,600,000 5,400,000              
Goodwill acquired   240,626,000 225,335,000 222,200,000 8,700,000 5,900,000 2,800,000 9,800,000 10,900,000              
Intangible assets acquired         10,700,000                      
Amortizable intangible assets acquired         8,700,000                      
Net assumed liabilities         (100,000)     (500,000)                
Amortization period for intangible assets                   6 years 6 years 7 years 7 years 6 years 6 years  
Research and development asset acquired fair value   2,000,000                           2,000,000
Cash consideration held back               2,600,000                
Net assets acquired                 $ 4,500,000